Background/Aim. Numerous trials have shown high success of radiofrequency ablation
Introduction
Importance of radiofrequency ablation (RFA) in treatment of atrial and ventricular arrhythmias is high and success of procedure increase every day due to new methods and techniques 1 . RFA is the most successful therapy for typical atrial flutter (AF), atrioventricular nodal reentrant tachycardia (AVNRT), Wolf-Parkinson-White (WPW) syndrome and idiopathic ventricular tachycardia (VT), effective in over 95% of patients 2 .
These patients don't need antiarrhythmic drugs after successful RFA.
The success rate of RFA is lower for management of premature ventricular complexes (PVC) and VT in structural heart diseases, 75-85% after follow-up of patients 3 .
RFA of pulmonary veins (PV) is newest field in therapy of atrial fibrillation (AFib) with greatest good results in paroxysmal form of this disease, success about 80% after 5 years follow-up of patients 4 .
The aim of this study was to examine initial success of RFA in treatment of atrial and ventricular arrhythmias and to evaluate RFA success after 6 months of patients followup. Also we aimed to investigate influence of all clinical and echocardiography parameters on initial and 6-months success of RFA and initial and 6-months failure of RFA.
Methods
The present study included 320 consecutive patients with different cardiac arrhythmias in which RFA was performed during 2014 year in the Institute for Cardiovascular Diseases Dedinje. We divided patients in the following 8 groups: RFA of AF, RFA of atrial tachycardia (AT), RFA of PV, RFA of AV node, RFA of AVNRT, RFA of PVC, RFA of VT and RFA of WPW syndrome. In each group we examined: 1. initial success of RFA and success after 6 months of patients follow-up 2. prognostic role of all clinical and echocardiography parameters on initial and 6-months RFA success 3.
prognostic influence of clinical and echocardiography parameters on initial and 6-months failure of RFA.
We evaluated in all patients clinical symptoms and signs, electrocardiogram, 24-h ambulatory monitoring, echocardiography and performed electrophysiology study and RFA. Transoesophageal echocardiography (TEE) was done in all patients in groups for RFA of AF, AT and PV with paroxysmal and persistent arrhythmias: we examined presence of thrombus in left auricula and left atrium; also anatomy of left, right, superior and inferior PV because of significant inter-and intra-patient variability in the number, size and bifurcation of the PVs. Patients with thrombus were excluded from study because of risk of cerebral insult. MSCT of PV was performed in all patients in group for RFA of atrial fibrillation and together with images from TEE provided better visualization of PVs.
Expert with skill manipulation introduce catheter for ablation in pathoanatomic substrate which cause arrhythmia and with delivering of RF energy make limited lesion, a few millimeters wide and deep in endocard. The RF energy was applied at a target temperature of 50⁰ with a power limit to 30-35 W for 30-60s.
This trial determined RFA initial success, RFA success after 6 months of follow-up and influence of all clinical and invasive parameters on procedural success and failure. We defined initial success as termination and inability to induce arrhythmia after catheter ablation. Success for RFA of AF means achievement of the bidirectional block in cavotricuspidal isthmus. The endpoint for RFA of PV was establishment of the bidirectional block between left atrium and PV. Failure of RFA means that after procedure we can induce identical tachycardia like before RFA. 
Results
During 2014 year in the Institute for Cardiovascular Diseases Dedinje RFA was performed in 320 patients with initial success in 93% and failure in 7%, respectively effective in 296 patients and unsuccessful in 24 cases (Table 1) . The RFA success rate after 6 months of follow-up was 83% (267 cases) because of 29 patients had recurrence of arrhythmia (10%). Total number of patients who had ineffective RFA after 6 months of follow-up was 53 (17%) and they were indicated for repeat intervention.
RFA of AF was done in 38 patients (36 with typical AF and 2 with atypical AF) which baseline characteristics prior initial procedure are shown in Table 2 . RFA initial success rate in AF was 92%, relatively 35 patients had successful RFA and in 8% (3 cases) was ineffectual. After 6 months of follow-up only 1 case has recurrence of AF and we calculated success for RFA of AF in 90% (34 cases) and failure in 10% (4 patients Initial success rate of RFA in 9 patients with AT was 78%, relatively in 7 cases
RFA was effective and in 22% (2 cases) was unsuccessful. After 6 months of follow-up 1 case had recidivism of AT and RFA of AT had good result in 67% (6 patients) and failure in 33% (3 patients).
RFA of PV was performed in 76 patients (65 males and 11 females) with diagnosis of AFib and mean age 55±8 years (Table 2 ). Average duration of symptoms was 5±4 years and syncope had 8 patients (11%). Echocardiography found mean values for EF 55±8%
(range 20-65%), EDD 54±4mm, ESD 36±5mm and diameter of LA 42±5mm (between 30-53mm). According to the duration AFib was divided in two types: paroxysmal AFib in 49 patients (65%) and persistent AFib in 27 cases (35%).
Initial success rate for RFA of PV in 76 patients with AFib was 99%, which means that in 75 patients RFA was effective and unsuccessful in 1% (1 patient). Complications for RFA of PV were reported in 6 patients: 1 patient had pericardial effusion and 4 patients had hematoma on place of punction (Table 3 ). These complications were cured conservatively except in one case of vein jugular hematoma when vascular surgery had to be done. In one patient ablation catheter clenched in chordaes of myocardium and cardiac surgery solved the problem.
Initial success rate for RFA of AV node in 11 patients with permanent tachyarrhythmia absolute was 100%, which means that in all patients RFA was effective.
After 6 months of follow-up there was not relapse of arrhythmia and success rate for RFA of AV node remained 100%.
RFA of AVNRT was efficient in all 50 patients with initial success of 100%. After 6 months of follow-up RFA of AVNRT had success in 94% (47 patients) and recurrence of tachycardia in 6% (3 patients) which were indicated for repeat intervention.
Electrophysiology study prior RFA diagnosed typical slow-fast AVNRT in all 50 patients.
RFA of PVC was performed in 45 patients (17 males and 28 females) with mean age 46±15 years (interval 18-77 years). Average duration of symptoms was 6±5 years (range 1-20 years) and syncope had 8 patients (18% and indication for surgery of mitral valve.
Initial success rate for RFA of VT in 47 patients was 85%, which means that in 40 patients RFA was efficient and failure happened in 7 cases (15%). After 6 months of follow-up 4 patients (8%) had recurrence of VT, and success rate was 77% (36 patients) and failure of ablation of VT after follow-up was 23% (11 patients). Location of ablated VT was described in right ventricle in 27% (13 patients), left ventricle in 49% (22 patients), epicardial in 18% (9 patients) and fascicular VT in 6% (3 patients). In right ventricle VT form outflow tract was presented in 23% (11 cases) and from tricuspid annulus in 4% (2 cases). In left ventricle VT from outflow tract was in 4% (2 cases), mitral annulus in 4%
and most common free wall was in 34% (16 patients). One patient had VT origin from post infarct psudoaneurysm in posteroseptal part of left ventricle and in one case VT was from papillary muscle. Approach for RFA depended of VT site of origin: retroaortal in 32% (14 cases), through femoral vein in 27% (13 patients), transseptalis access in 23% (11 patients) and epicardial approach in 18% (9 patients). After RFA of VT in 10 patients implantable cardioverter defibrillator was indicated because of control electrophysiological study induced fast VT or ventricular fibrillation. We did not prove influence of VT localization, clinical and echocardiography parameters on initial and 6-months success or failure of RFA.
There were 4 complications of VT catheter ablation: 2 inguinal hematomas were managed conservatively, 1 cardiac tamponade was cured with pericardiocentesis and 1 complete AV block was treated with implantation of pacemaker (Table 3) .
Initial success for RFA of WPW syndrome in 44 patients was 87%, respectively in 39 patients was good result and in 13% was ineffective (5 patients). After 6 months of follow-up recurrence happened in 1 case (1%), and RFA success rate was 86% (efficient in 38 cases) and failure in 14% (6 patients). According to localization accessory pathways (AP) were classified: right ventricular free wall in 5 cases (13%), left ventricular free wall in 19 cases (43%), septal position in 19 cases (43%) and epicardial location in 1 case (1%).
We did not find any prognostic role of parameters on initial and 6-months success or failure of RFA. We described two complications of catheter ablation of AP: in one case complete AV block was managed with implantation of pacemaker, and in another case cardiac tamponade was treated with pericardiocentesis (Table 3 ).
Significant complications of RFA were reported in 12 patients of 320 (3.75%).
There were not procedure related deaths.
Discussion
The Group with ablated AT has small number of patients, so we cannot compare our result with other trials where success rate was 93% for right atrium AT and smaller for left atrium AT 6 .
The present study shows eminent initial success of 99% in patients with ablated PV.
We prove RFA success after 6 months of follow up in 79% and significantly better outcome (p˂0.05) in patients with paroxysmal AFib (success rate 88%) than those with persistent AFib (success rate 63%). Sohns et al. found initial success for catheter ablation of PV in 92% and after 2 years follow up was 81% for paroxysmal AFib and 76% for persistent form 7 . Large number of studies identified predictors of a poor outcome following RFA of PV: 1. non-paroxysmal AFib and particulary longstanding persistent AFib, 2.
increased atrial size, 3. sleep apnea and obesity, 4. elderly patients, 5. decreased left ventricular function 6. left atrial fibrosis as detected by cardiac MRI 8 . We proved only one predictor (paroxysmal AFib) of a good 6-months prognosis in our patients with ablated PV.
Limitations of our study are small number of cases and only 6 months follow-up after RFA of PV compare to other trials with bigger number of patients and longer follow-up 4, 7, 8 .
Numerous trials reported recurrence of AFib after RFA of PV in 20-40% of patients, while recidivism of AFib is 20% in our patients after 6 months of follow-up 4, 6 .
Early relapse of AFib and/or AT is frequent during first 3 months after catheter ablation of PV and can spontaneously vanish, so experts made consensus that repeat RFA is not recommended during this time 4 . Also they concluded that in some patients which have highly symptomatic atrial arrhythmias resistant on treatment with antiarrhythmic drugs it is recommended to ablate PV within 3 months after first intervention. Most of the studies confirmed that patients which had recurrence and underwent repeat RFA had most frequently origin of AFib from already ablated PV and rarely from new focus in non ablated PV and another location in atrium 4, 7, 8 .
Treatment of drug resistant permanent tachyarrhythmia absolute in our patients with RFA of AV node has excellent initial success in 100% without recurrence after 6 months of follow-up. Numerous trials showed success rate in 99-100% for RFA of AV node 2 .
The present study reports fantastic initial success of 100% for RFA of AVNRT and after 6 months of patients follow-up success is 94%. Stern et al. revealed initial success in 98% of cases for RFA of AVNRT and after 3 months of follow up recurrence was 2% 9 . All our patients have typical slow-fast form of AVNRT, while in literature this form was described in 90% of cases 6 .
RFA of PVC in our patients has initial success of 87% and after 6 months of follow-up success is 78%. Numerous studies revealed initial success for RFA of PVC in 80-90% 10, 11 .
RFA of VT has initial good results in 85% of our patients and after 6 months of follow-up success is 77%. Famous electrophysiology laboratories have 17% of epicardial mapping while our results for RFA of epicardial VT is distinguished 18% 12 . Pederson et al. This study finds modest initial success for RFA of WPW syndrome in 87% and after 6 months of follow-up success in 86% of cases. In literature initial good results for RFA of accessory pathway was 99% and after 3 months of follow-up recidivism was 2% 13 .
We do not find prognostic role of AP location, clinical and echocardiography parameters in group of patients with RFA of AP. In largest trial on thousand fifty patients Calkins et al.
reported that success rate for catheter ablation of left free wall APs was slightly higher than for RFA of right-sided APs (95% vs 90%, P = 0.03) 14 . After an initially successful procedure in 93% of patients, recurrence of AP conduction was found in approximately 5% of cases 14 . The recurrence-free interval after ablation was also best with left-sided pathways 14 .
Limitations of the present study are 8 groups of different arrhythmias with small number of patients and short 6-months follow-up. Those facts influenced that we find only one prognostic parameter -type of atrial fibrillation in group of patients with ablated PV.
The data from present trial will be included in future study with bigger number of cases and longer follow-up.
This study shows significant RFA complications in 12 patients of 320 (3.75%),
which is acceptable and can compare with result (3-4.2%) from other eminent electrophysiology laboratories 2 . There have not been deaths during RFA in our patients which are excellent results.
According to our results and data from literature we conclude that RFA is safe procedure that continuously evolving, with great success in treatment of cardiac arrhythmias. Catheter ablation is therapy of choice for management of typical AF, AVNRT, WPW syndrome and idiopathic VT.
Conclusion
The present study proved very high RFA initial success in treatment of atrial and ventricular arrhythmias and satisfactory RFA success after 6 months of follow-up. Only prognostic value had type of atrial fibrillation in group with catheter ablated pulmonary veins: after 6 months follow-up patients with paroxysmal atrial fibrillation had significantly better outcome than those with persistent form.
This trial shows great success of RFA with high importance and possibility in therapy of cardiac arrhythmias, which can be compared with results in famous electrophysiology laboratories. 
